1832 Asset Management
CRSP icon

1832 Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

1832 Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,000
Closed -$1.13M – 886
2023
Q4 		$1.13M Buy
+18,000
New +$1.13M ﹤0.01% 557